These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19253011)

  • 1. Case-control study of thromboembolic events associated with IV immunoglobulin.
    Caress JB; Hobson-Webb L; Passmore LV; Finkbiner AP; Cartwright MS
    J Neurol; 2009 Mar; 256(3):339-42. PubMed ID: 19253011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolic complications of intravenous immunoglobulin treatment.
    Vucic S; Chong PS; Dawson KT; Cudkowicz M; Cros D
    Eur Neurol; 2004; 52(3):141-4. PubMed ID: 15479982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
    Lidar M; Masarwa S; Rotman P; Carmi O; Rabinowicz N; Levy Y
    Immunol Res; 2018 Dec; 66(6):668-674. PubMed ID: 30565202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort study.
    Ramírez E; Romero-Garrido JA; López-Granados E; Borobia AM; Pérez T; Medrano N; Rueda C; Tong HY; Herrero A; Frías J
    Thromb Res; 2014 Jun; 133(6):1045-51. PubMed ID: 24731561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy.
    Ammann EM; Jones MP; Link BK; Carnahan RM; Winiecki SK; Torner JC; McDowell BD; Fireman BH; Chrischilles EA
    Blood; 2016 Jan; 127(2):200-7. PubMed ID: 26443622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.
    Ammann EM; Haskins CB; Fillman KM; Ritter RL; Gu X; Winiecki SK; Carnahan RM; Torner JC; Fireman BH; Jones MP; Chrischilles EA
    Am J Hematol; 2016 Jun; 91(6):594-605. PubMed ID: 26973084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
    Davé S; Hagan J
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic complications following intravenous immunoglobulin therapy in immune-mediated neurological disorders.
    Chun W; Kim Y; Park SH; Choi SJ
    J Clin Neurosci; 2021 Aug; 90():311-316. PubMed ID: 34275568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: intravenous immunoglobulin therapy and thromboembolic complications.
    Katz U; Shoenfeld Y
    Lupus; 2005; 14(10):802-8. PubMed ID: 16302674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1354-64. PubMed ID: 12867585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: a two-year study.
    Rajabally YA; Kearney DA
    J Neurol Sci; 2011 Sep; 308(1-2):124-7. PubMed ID: 21679973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty.
    Madsen RV; Nielsen CS; Kallemose T; Husted H; Troelsen A
    J Arthroplasty; 2017 Apr; 32(4):1298-1303. PubMed ID: 27843042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.
    Hefer D; Jaloudi M
    Ann Hematol; 2004 Oct; 83(10):661-5. PubMed ID: 15309520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Heeley E; Hughes K; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1342-53. PubMed ID: 12832706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thrombotic events after inpatient intravenous immunoglobulin or plasma exchange for neurologic disease: A case-crossover study.
    Jin PH; Shin SC; Dhamoon MS
    Muscle Nerve; 2020 Sep; 62(3):327-332. PubMed ID: 32270520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin: adverse effects and safe administration.
    Orbach H; Katz U; Sherer Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.
    Vo AA; Cam V; Toyoda M; Puliyanda DP; Lukovsky M; Bunnapradist S; Peng A; Yang K; Jordan SC
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):844-52. PubMed ID: 17699296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.